EN
抗体药类似物
Research Grade Cosfroviximab
All
TD-VK623036_1.jpg
TD-VK623036_2.jpg
  • CatalogTD-VK623036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • Synonymsc13C6-FR1-N,CAS:1792982-57-0
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Cosfroviximab


Catalog No. TD-VK623036
Species reactivity Zaire ebolavirus (ZEBOV)
Applications Research Grade Biosimilar
Host species Chimeric
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Envelope glycoprotein, GP1,2, GP, Shed GP, GP1,2-delta, GP1, GP2, GP
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q05320
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names c13C6-FR1-N,CAS:1792982-57-0
Background Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP).
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK623036_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Cosfroviximab.
TD-VK623036_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Cosfroviximab.